|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-7-16
|
|
pubmed:abstractText |
To evaluate the activity of a new cephalosporin, ceftaroline, in comparison with other antistaphylococcal drugs (linezolid and vancomycin) at projected human therapeutic doses against methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-intermediate S. aureus (GISA) strains.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1460-2091
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1749-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20530506-Acetamides,
pubmed-meshheading:20530506-Animals,
pubmed-meshheading:20530506-Anti-Bacterial Agents,
pubmed-meshheading:20530506-Bone Marrow,
pubmed-meshheading:20530506-Bone and Bones,
pubmed-meshheading:20530506-Cephalosporins,
pubmed-meshheading:20530506-Disease Models, Animal,
pubmed-meshheading:20530506-Female,
pubmed-meshheading:20530506-Methicillin-Resistant Staphylococcus aureus,
pubmed-meshheading:20530506-Osteomyelitis,
pubmed-meshheading:20530506-Oxazolidinones,
pubmed-meshheading:20530506-Rabbits,
pubmed-meshheading:20530506-Staphylococcal Infections,
pubmed-meshheading:20530506-Treatment Outcome,
pubmed-meshheading:20530506-Vancomycin
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
|
|
pubmed:affiliation |
Université de Nantes, Faculté de Médecine, Thérapeutiques Cliniques et Expérimentales des Infections, EA3826, F-44000 Nantes, France. cedric.jacqueline@univ-nantes.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
